DMK-30699-16680
4 vaccinations
9 coded responses
31 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 212 / MD
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Registered in v-safe
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Sore arm pitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
- 2021-01-19
- 2021-01-21
-
2021-01-28
Survey response — day 14, dose 1MedDRA: Unevaluable event, Vision blurred — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Increased blurry vision. Not sure if its related or not. · Healthcare visit (other): Eye dr appointment scheduled for next weekMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-04
-
2021-02-10
Dose 2 — Pfizer-BioNTech
- 2021-02-10
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Flatulence — Feeling: Good · Site: Pain · Headache, Muscle or body achesFree text: GasMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-13
- 2021-02-14
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Fair · HeadacheFree text: Racing heartMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-10
-
2021-03-17
Survey response — day 35, dose 2MedDRA: Headache, Paranasal sinus discomfort — Feeling: FairFree text: Headache, sinus pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-05-27
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-10
- 2021-10-16
-
2022-01-02
Survey response — 3 months, dose 3MedDRA: Dermatitis, Rash — Feeling: FairFree text: Skin rashes and inflammationMedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Dose 4 — Pfizer-BioNTech
- 2022-04-18
- 2022-04-22
- 2022-04-30
- 2022-05-06
-
2022-05-14
Survey response — day 35, dose 4MedDRA: Condition aggravated, Joint stiffness, Pre-existing disease — Feeling: GoodFree text: Not sure if it's related but I continue to have more joint stiffness than I did pre-booster. In retrospect, I feel like I also had a flare of joint stiffness after my fall booster.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Survey response — day 42, dose 4MedDRA: Arthralgia, Joint stiffness, Neuropathy peripheral — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Joint stiffness, pain and neuropathyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-23
-
2022-05-24
Call successfulParticipant prefers to complete VAERS report online
-
2022-05-24
Call successfulParticipant prefers to complete VAERS report online
-
2022-07-09
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-07-09
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-12
- 2022-07-12
- 2022-07-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Sore arm pits
Release 2 — day 14, dose 1
Symptoms: Increased blurry vision. Not sure if its related or not.
Healthcare visit (other): Eye dr appointment scheduled for next week
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Gas
Systemic reaction (other): Racing heart
Release 5 — day 35, dose 2
Symptoms: Headache, sinus pressure
Release 10 — 3 months, dose 3
Symptoms: Skin rashes and inflammation
Release 11 — day 35, dose 4
Symptoms: Not sure if it's related but I continue to have more joint stiffness than I did pre-booster. In retrospect, I feel like I also had a flare of joint stiffness after my fall booster.
Release 11 — day 42, dose 4
Symptoms: Joint stiffness, pain and neuropathy
Release 12 — 3 months, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dermatitis | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Joint stiffness | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Flatulence | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release